Lung Cancer News and Research

Latest Lung Cancer News and Research

Will the future of global health rely upon addressing air pollution?

We speak to Dr. Philip Landrigan about his latest research into air pollution and how African countries are in a prime position to take action against it.

12 Nov 2021

COVID-19 trends identified from multiple linked EHR

In this study, the sociodemographic factors, occurrence of health conditions, the effect of the first and second waves in England, and vaccination effects, were considered separately.

11 Nov 2021

Proton therapy used for the first time in Switzerland to treat lung cancer

Today a 60-year-old patient suffering from lung cancer received proton beam therapy, a medical procedure where positively charged particles are precisely targeted at the tumor. This is the first time this type of radiotherapy has been used for lung cancer treatment in Switzerland.

9 Nov 2021

Researchers develop model for early prediction of cancer patients' response to immunotherapy

Researchers have developed a model that could predict early on in treatment whether cancer patients will respond to immunotherapy, according to a report published today in eLife.

9 Nov 2021

Oncologists use immunotherapy at faster rates for trial-ineligible patients, study finds

Cancer patients who are ineligible for clinical trials receive immune checkpoint inhibitors (ICI) at greater rates than patients who are trial eligible despite no survival benefit, according to a new study by researchers at the Perelman School of Medicine at the University of Pennsylvania.

9 Nov 2021

People of color, lower-income residents in DC disproportionally affected by air pollution

The rates of death and health burdens associated with air pollution are borne unequally and inequitably by people of color and those with lower household income and educational attainment in Washington, D.C., according to a new study.

8 Nov 2021

Study points to a new, effective treatment option for patients with mesothelioma

Combining the immunotherapy agent durvalumab with the chemotherapy agents pemetrexed and cisplatin or carboplatin may provide a new treatment option for patients who have inoperable pleural mesothelioma, a cancer of the tissues lining the lungs, according to a phase II clinical trial led by researchers at the Johns Hopkins Kimmel Cancer Center and the Bloomberg~Kimmel Institute for Cancer Immunotherapy.

8 Nov 2021

Study opens a window for new therapeutic approaches to ovarian cancer

A Ludwig Cancer Research study has uncovered a cellular interaction that is essential to the ability of the immune system's cytotoxic T lymphocytes to destroy ovarian tumors and shown that its engagement could help determine the efficacy of checkpoint blockade immunotherapy in a variety of cancers.

6 Nov 2021

How does a surgeon’s language affect patient risk perception?

In this interview, we speak to Dr. Joshua E. Rosen about his latest research into treatment options and what role a surgeon’s language plays in people's perception of its risks.

4 Nov 2021

Unmet physical and psychological needs impact lung cancer patients' quality of life

Research published in the European Journal of Cancer Care suggests that unmet physical and psychological needs of patients with lung cancer have a significant impact on patients' quality of life and affect their ability to continue with everyday activities.

3 Nov 2021

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

Cancer is the second leading cause of death in New York State after heart disease among adults and the second cause of death among children after injuries. And the number of people diagnosed with the disease increases every year.

2 Nov 2021

Deaths from smoking-related cancers expected to increase in China over the next 20 years

Deaths from smoking-related cancers in China are expected to rise by almost 50% over the next two decades, finds research published online in the journal Tobacco Control.

2 Nov 2021

Immune checkpoint protein may be a promising new target for prostate cancer immunotherapy

The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center.

2 Nov 2021

Understanding the current medical landscape of prostate cancer

In this interview, News-Medical talks to Dr. Simon Chowdhury and Laetitia Guilloux about the current state of prostate cancer, it's prevalence, treatment options and its future.

From Janssen Pharmaceuticals 2 Nov 2021

Researchers decipher when and why T cells become non-responsive to immunotherapy

Non-small cell lung cancer is the most common type of lung cancer in humans. Some patients with NSCLC receive a therapy called immune checkpoint blockade (ICB) that helps kill cancer cells by reinvigorating a subset of immune cells called T cells, which are "exhausted" and have stopped working.

30 Oct 2021

Lung cancer-associated fibroblasts could guide the design of personalized treatments

Three subtypes of cancer-associated fibroblasts (CAF) could guide the design of personalized treatment for lung cancer patients, according to a new study in Cancer Cell led by researchers at Massachusetts General Hospital.

26 Oct 2021

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Israeli researchers evaluate the antibody response in ICPs to assess antibody-mediated immunity following vaccination with the Pfizer-BioNTech vaccine.

26 Oct 2021

Intervention erases Black-white survival gaps in early-stage lung and breast cancer patients

A new study shows that system-level changes to the way cancer care is delivered can also eliminate Black-white disparities in survival from early-stage lung and breast cancer.

25 Oct 2021

Telemedicine approach remains a viable alternative for lung cancer screening

A novel telemedicine lung cancer screening effort during the COVID-19 pandemic shows that virtual single-visit screenings are just as effective as single-visit screenings done in person at the hospital, according to a study presented at the American College of Surgeons Virtual Clinical Congress 2021.

25 Oct 2021

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

A new study posted to the medRxiv* preprint server studies the neutralizing antibody response in cancer patients diagnosed with chronic lymphocytic leukemia (CLL), lung cancer, breast cancer, and various non-Hodgkin’s lymphomas (NHL), post-reception of two doses of messenger RNA (mRNA) vaccines.

25 Oct 2021

Lung Cancer News and Research

Latest Lung Cancer News and Research

Will the future of global health rely upon addressing air pollution?

COVID-19 trends identified from multiple linked EHR

Proton therapy used for the first time in Switzerland to treat lung cancer

Researchers develop model for early prediction of cancer patients' response to immunotherapy

Oncologists use immunotherapy at faster rates for trial-ineligible patients, study finds

People of color, lower-income residents in DC disproportionally affected by air pollution

Study points to a new, effective treatment option for patients with mesothelioma

Study opens a window for new therapeutic approaches to ovarian cancer

How does a surgeon’s language affect patient risk perception?

Unmet physical and psychological needs impact lung cancer patients' quality of life

Brooklyn College announces the launch of BCCC-CURE to enhance the lives of cancer patients

Deaths from smoking-related cancers expected to increase in China over the next 20 years

Immune checkpoint protein may be a promising new target for prostate cancer immunotherapy

Understanding the current medical landscape of prostate cancer

Researchers decipher when and why T cells become non-responsive to immunotherapy

Lung cancer-associated fibroblasts could guide the design of personalized treatments

Effectiveness of mRNA BNT162b2 COVID-19 vaccine in immunocompromised individuals

Intervention erases Black-white survival gaps in early-stage lung and breast cancer patients

Telemedicine approach remains a viable alternative for lung cancer screening

Cancer patients have impaired antibody responses to COVID-19 mRNA vaccines

The ultimate guide to lung research tools and protocols eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Lung Cancer News and Research

Latest Lung Cancer News and Research

The ultimate guide to lung research tools and protocols eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in